Evidence map›Paper›PMID 33495854›Full record

ArticleZeitschrift fur Rheumatologie2021

[Threat of a SARS-CoV-2 endemic in a large hospital specialized in rheumatic diseases-relative all clear through consistent testing].

I Andreica, B Guminski, J Sokolar, A Patru, X Baraliakos, J Braun

Abstract read
In one paragraph

Article in Zeitschrift fur Rheumatologie, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

I AndreicaRheumazentrum Ruhrgebiet und Ruhr-Universität Bochum, Claudiusstr. 45, 44649, Herne, Deutschland.
B GuminskiRheumazentrum Ruhrgebiet und Ruhr-Universität Bochum, Claudiusstr. 45, 44649, Herne, Deutschland.
J SokolarRheumazentrum Ruhrgebiet und Ruhr-Universität Bochum, Claudiusstr. 45, 44649, Herne, Deutschland.
A PatruRheumazentrum Ruhrgebiet und Ruhr-Universität Bochum, Claudiusstr. 45, 44649, Herne, Deutschland.
X BaraliakosRheumazentrum Ruhrgebiet und Ruhr-Universität Bochum, Claudiusstr. 45, 44649, Herne, Deutschland.
J BraunRheumazentrum Ruhrgebiet und Ruhr-Universität Bochum, Claudiusstr. 45, 44649, Herne, Deutschland. juergen.braun@elisabethgruppe.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The severe acute respiratory coronavirus type 2 (SARS-CoV-2) pandemic is keeping most countries of the world in suspense. In Germany the prevalence of SARS-CoV‑2 infections is under 2% but for weeks the numbers in Germany have also been increasing. The care in rheumatology was temporarily impaired by the first wave of the pandemic. This article reports the infection situation in the largest specialized rheumatology clinic in Germany, the Rheumatism Center Ruhrgebiet, because recently during the second wave for the first time several SARS-CoV‑2 infections occurred here over one weekend, which led to considerable anxiety in many of those involved. The situation could be clarified by consistent testing of patients and personnel with the rapid antigen test and the situation could be mollified. Ultimately, only a few persons were tested positive and the courses by the patients have so far remained bland. This shows the effectiveness of the protective hygiene measures consistently implemented since April.

Indexed as

COVID-19Rheumatic DiseasesGermanyHospitalsHumansNaphazolineSARS-CoV-2NaphazolineCorona hygiene conceptCOVID-19Hospital for rheumatic diseasesPandemicSARS-CoV-2 antigen test

Identifiers

PMID33495854
PMCPMC7832413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.